Efficacy and tolerability of mogamulizumab in mycosis fungoides and Sézary Syndrome: a monocentric retrospective study
The results of this study reaffirm the efficacy of Mogamulizumab therapy for patients with Mycosis Fungoides and Sézary Syndrome in a real-world setting, which involves treatment decisions that must often consider patient heterogeneity, comorbidities, and prior lines of therapy.
Authors
- Marianna Criscuolo (ORCID: https://orcid.org/0000-0001-5661-2338)
- Alessia Di Pilla
- Martina Quattrone
- L Pagano
- Antonio Giordano
- Luana Fianchi
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-01-22
- DOI
- https://doi.org/10.3389/fonc.2025.1748746
- Primary Topic
- Cutaneous lymphoproliferative disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00